Outcomes of Adults and Children with Primary Mediastinal B-Cell Lymphoma Treated with Dose-Adjusted EPOCH-R

Treatment with dose-adjusted EPOCH (etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone) chemotherapy and rituximab (DA-EPOCH-R) has become the standard of care for primary mediastinal B-cell lymphoma (PMBCL) at many institutions despite limited data in the multi-centre setting. We rep...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Haematol
Main Authors: Giulino-Roth, Lisa, O’Donohue, Tara, Chen, Zhengming, Bartlett, Nancy L., LaCasce, Ann, Martin-Doyle, William, Barth, Matthew J., Davies, Kimberly, Blum, Kristie A., Christian, Beth, Casulo, Carla, Smith, Sonali M., Godfrey, James, Termuhlen, Amanda, Oberley, Matthew J., Alexander, Sarah, Weitzman, Sheila, Appel, Burton, Mizukawa, Benjamin, Svoboda, Jakub, Afify, Zeinab, Pauly, Melinda, Dave, Hema, Gardner, Rebecca, Stephens, Deborah M., Zeitler, William A., Forlenza, Christopher, Levine, Jennifer, Williams, Michael E., Sima, Jody L., Bollard, Catherine M., Leonard, John P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6650639/
https://ncbi.nlm.nih.gov/pubmed/29082519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.14951
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados